In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.Content:- What are the phases of multiple myeloma treatment?- How do we determine transplant eligibility?- What does doublet, triplet, and quadruplet therapy mean? - What categorizes "high risk" myeloma?- What are the current standards of care for transplant eligible patients? - Where does "CyBorD" fit in for treatment? - When do we consider adding daratumumab? - Links to key trialsThis episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co.Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast